Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...

Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...

This session delves into the complexities of managing complications during STEMI interventions. Through real-world cases from Algeria, Malaysia, and Pakistan, it provides comprehensive analyses of challenging scenarios, treatment strategies, and key learnings, emphasizing the critical decision-making required to navigate complications and improve patient outcomes in high-stakes...

This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...

Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.

Explore pioneering advancements in coronary interventions with first-in-man and novel devices. This session presents groundbreaking studies including cryotherapy for vulnerable plaques, a novel intravascular crossing system for coronary CTOs, sirolimus-coated retrievable scaffold therapy for in-stent restenosis, real-time intravascular photoacoustic imaging of lipid-rich plaques, and the inaugural...

Watch the video on demand with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre

Watch the video on demand with leading experts Bernard Prendergast, Markus Kasel and Won-Keun Kim

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.

This case highlights the potential add-on value of reduced-order computational modeling over standard CT scan analysis due to its ability to predict the interaction of different devices or sizes with the patient-specific anatomy.

Paris, France, 16 May 2023. Within 20 years of its first appearance on the clinical stage, transfemoral transcatheter aortic valve implantation (TF-TAVI) has become an established treatment option for patients with symptomatic severe aortic stenosis (AS) that is supported by Class IA recommendations in current European and...

Paris, France. At EuroPCR 2023, the interventional community paid tribute to Emergency Medical Services throughout the world for their critical role in enabling timely care. International representatives of emergency medical services received the Andreas Grüntzig Ethica Award at the opening ceremony of this year’s Course, further...

Paris, France, 17 May 2023.  The field of coronary drug-coated balloon (DCB) angioplasty looks set to assume growing importance in the years to come and the potential for increased use of these devices in clinical practice is considerable.

EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied...

EuroPCR is celebrating being back home in Paris, in-person, for the first time in 3 years. This year’s international Course will see both a complete on-site programme and a full digital experience, bringing the community together to share and learn.

Paris, France. 21 May 2021.  Since 1989, EuroPCR has constantly pioneered innovative educational tools and formats to help the interventional cardiovascular community effectively share their knowledge, skills and practice. Rising up to the challenge of the pandemic, the 31st annual edition was fundamentally rethought, reshaped and...

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.